FIELD: medicine, microbiology. SUBSTANCE: method involves selection of feces samples from a single organism from its clinically health state beginning from 7-15 postnatal life and during spanlife by analysis once per a year. Autostrains of normal intestine microflora are isolated from samples and identified. Biomass of each bacterium species is produced separately on selective nutrient media to titer 103-109 cells/ml, not less. Obtained biomasses are combined, stabilizing composition is added and a mixture is divided for samples. Each sample is preserved and stored for human spanlife under periodical biotiter monitoring. At infant age (less 1 year) normal intestine microflora has the following bifidobacteria of species: Bifidobacterium bifidum, Bifidobacterium brevis, Bifidobacterium infantis and lactobacteria of species Lactobacillus acidophilus, Lactobacillus fermenti. At age above 1 year normal species of intestine microflora are mainly Bifidobacterium longum, Bifidobacterium adolescents, lactobacteria of species Lactobacillus acidophilus, Lactobacillus fermenti, Lactobacillus plantarum, strains of bacteria Escherichia coli and lactic acid streptococci of species mainly Streptococcus faecium, Streptococcum faecalis, Streptococcus avium, Streptococcus salivarius and Streptococcus bovis. During storage after biotiter control samples of bacterium autostrains isolated from normal human intestine microflora taken off at different spanlife are combined at an equal ratios. Administration of microorganism autostrains bank samples in human intestine ensures to effect on different links of damaged intestine bacteriocenosis simultaneously by means of using the more complete spectrum of normal intestine microflora. Invention can be used for prophylaxis and treatment of patients with intestine disbacteriosis in human. EFFECT: improved method of bank preparing, enhanced effectiveness of treatment. 7 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
FERMENTED-MILK DRIED PRODUCT "NARINE" | 1999 |
|
RU2147183C1 |
METHOD FOR TREATING IMMUNODEFICIENCY STATES OF ORGANISM | 1999 |
|
RU2149633C1 |
STRAIN OF BACTERIUM LACTOBACILLUS ACIDOPHILUS NV EP 317/402-X "BALANS-NARINE" USED FOR PREPARING ANTIGASTRITIS AND ANTIULCEROUS FERMENTED-MILK PRODUCT | 2001 |
|
RU2203946C1 |
METHOD OF PREPARING BIOLOGICALLY ACTIVE COMPLEX FOR THE FOOD OR COSMETIC AGENT MAKING | 1997 |
|
RU2110182C1 |
CULTURED-MILK PRODUCT "NARINE" FOR PRODUCTION OF DESSERT IN FROZEN CONDITION | 1999 |
|
RU2141766C1 |
METHOD FOR APPLYING WAVE ACTION TO PATHOGENIC MICROORGANISMS, VIRUSES AND TUMOR CELLS IN EXPERIMENT | 2003 |
|
RU2250788C2 |
METHOD FOR TREATING INTESTINAL DYSBACTERIOSIS | 1998 |
|
RU2159626C2 |
BACTERIAL PROBIOTIC PREPARATION | 2002 |
|
RU2253672C2 |
METHOD OF PREPARING A COSMETIC AGENT FOR SKIN CARE | 1997 |
|
RU2122397C1 |
FERMENTED MILK BEVERAGE | 2005 |
|
RU2284119C1 |
Authors
Dates
1999-02-10—Published
1997-07-29—Filed